Global Transdermal Medical Patch Market Size study, by Type, by Application, by Distribution Channel and Regional Forecasts 2022-2032

Description

Global Transdermal Medical Patch Market is valued at approximately USD 7.88 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5% over the forecast period 2024-2032. Transdermal medical patches, also known as medicated or skin patches, are innovative medical devices designed to deliver drugs or therapeutic substances through the skin into the bloodstream. This non-invasive drug delivery method is especially beneficial for chronic conditions requiring long-term treatment, providing patients with a convenient and pain-free administration method. The market for transdermal patches is being driven by several key factors, including the growing prevalence of chronic diseases, the aging population, and advancements in transdermal patch technology.

The primary advantage of transdermal patches over traditional oral or injectable medications is their ability to avoid gastrointestinal toxicity, reducing instances of nausea and vomiting. These patches facilitate self-administration of medication, enhancing patient comfort and adherence, particularly for chronic conditions like heart disease, diabetes, and arthritis. Furthermore, the convenience and consistent plasma drug concentrations offered by transdermal patches make them increasingly popular for managing chronic diseases, which is driving the global market's growth. Moreover, the escalating number of smokers and rising use of insulin delivery present various lucrative opportunities over the forecast years. However, the potential skin irritation and hypersensitivity as well as drug failure & recalls of transdermal drug delivery systems are challenging the market growth throughout the forecast period of 2024-2032.

The key regions considered for the Global Transdermal Medical Patch Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Global Transdermal Medical Patch Market in terms of revenue. The market growth in the region is being attributed to factors including a well-established healthcare infrastructure, high levels of healthcare spending, and the presence of leading pharmaceutical companies that invest heavily in research and development. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by a rapidly expanding healthcare sector, increasing urbanization, and a rising geriatric population that requires effective and convenient treatment options.

Major market player included in this report are:

Novartis AG
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Endo International PLC
Boehringer Ingelheim
Nitto Denko Corporation
Luye Pharma Group Ltd.
Hisamitsu Pharmaceutical Co., Inc.
Medline Industries, LP
Corium LLC
UCB S.A.
Teikoku Pharma USA, Inc.
3M Company
GlaxoSmithKline plc

The detailed segments and sub-segment of the market are explained below:

By Type:

Matrix
Single-Layer Drug In-Adhesive
Multi-Layer Drug In-Adhesive
Reservoir
Vapor Patch

By Application:

Pain Management
Hormonal Therapy
Nicotine Cessation
Cardiovascular Disorders
Neurologic Conditions
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:

North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with country-level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Transdermal Medical Patch Market Executive Summary

1.1. Global Transdermal Medical Patch Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Type
- 1.3.2. By Application
- 1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Transdermal Medical Patch Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Transdermal Medical Patch Market Dynamics

3.1. Market Drivers
- 3.1.1. Burgeoning Prevalence of Chronic Diseases
- 3.1.2. Rapid Expansion of Geriatric Population
- 3.1.3. Surging Demand for Non-Invasive Pain Management
3.2. Market Challenges
- 3.2.1. Potential Skin Irritation and Hypersensitivity
- 3.2.2. Drug Failure & Recalls of Transdermal Drug Delivery Systems
3.3. Market Opportunities
- 3.3.1. Escalating Number of Smokers
- 3.3.2. Rising Use of Insulin Delivery

Chapter 4. Global Transdermal Medical Patch Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Transdermal Medical Patch Market Size & Forecasts by Type 2022-2032

5.1. Segment Dashboard
5.2. Global Transdermal Medical Patch Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Matrix
- 5.2.2. Single-Layer Drug In-Adhesive
- 5.2.3. Multi-Layer Drug In-Adhesive
- 5.2.4. Reservoir
- 5.2.5. Vapor Patch

Chapter 6. Global Transdermal Medical Patch Market Size & Forecasts by Application 2022-2032

6.1. Segment Dashboard
6.2. Global Transdermal Medical Patch Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Pain Management
- 6.2.2. Hormonal Therapy
- 6.2.3. Nicotine Cessation
- 6.2.4. Cardiovascular Disorders
- 6.2.5. Neurologic Conditions
- 6.2.6. Others

Chapter 7. Global Transdermal Medical Patch Market Size & Forecasts by Distribution Channel 2022-2032

7.1. Segment Dashboard
7.2. Global Transdermal Medical Patch Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Hospital Pharmacies
- 7.2.2. Retail Pharmacies
- 7.2.3. Online Pharmacies

Chapter 8. Global Transdermal Medical Patch Market Size & Forecasts by Region 2022-2032

8.1. North America Transdermal Medical Patch Market
- 8.1.1. U.S. Transdermal Medical Patch Market
  - 8.1.1.1. Type Breakdown Size & Forecasts, 2022-2032
  - 8.1.1.2. Application Breakdown Size & Forecasts, 2022-2032
  - 8.1.1.3. Distribution Channel Breakdown Size & Forecasts, 2022-2032
- 8.1.2. Canada Transdermal Medical Patch Market
- 8.1.3. Mexico Transdermal Medical Patch Market
8.2. Europe Transdermal Medical Patch Market
- 8.2.1. UK Transdermal Medical Patch Market
- 8.2.2. Germany Transdermal Medical Patch Market
- 8.2.3. France Transdermal Medical Patch Market
- 8.2.4. Spain Transdermal Medical Patch Market
- 8.2.5. Italy Transdermal Medical Patch Market
- 8.2.6. Rest of Europe Transdermal Medical Patch Market
8.3. Asia-Pacific Transdermal Medical Patch Market
- 8.3.1. China Transdermal Medical Patch Market
- 8.3.2. India Transdermal Medical Patch Market
- 8.3.3. Japan Transdermal Medical Patch Market
- 8.3.4. Australia Transdermal Medical Patch Market
- 8.3.5. South Korea Transdermal Medical Patch Market
- 8.3.6. Rest of Asia Pacific Transdermal Medical Patch Market
8.4. Latin America Transdermal Medical Patch Market
- 8.4.1. Brazil Transdermal Medical Patch Market
- 8.4.2. Mexico Transdermal Medical Patch Market
- 8.4.3. Rest of Latin America Transdermal Medical Patch Market
8.5. Middle East & Africa Transdermal Medical Patch Market
- 8.5.1. Saudi Arabia Transdermal Medical Patch Market
- 8.5.2. South Africa Transdermal Medical Patch Market
- 8.5.3. Rest of Middle East & Africa Transdermal Medical Patch Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Novartis AG
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Johnson & Johnson
- 9.3.3. Teva Pharmaceutical Industries Ltd.
- 9.3.4. Viatris Inc.
- 9.3.5. Endo International PLC
- 9.3.6. Boehringer Ingelheim
- 9.3.7. Nitto Denko Corporation
- 9.3.8. Luye Pharma Group Ltd.
- 9.3.9. Hisamitsu Pharmaceutical Co., Inc.
- 9.3.10. Medline Industries, LP
- 9.3.11. Corium LLC
- 9.3.12. UCB S.A.
- 9.3.13. Teikoku Pharma USA, Inc.
- 9.3.14. 3M Company
- 9.3.15. GlaxoSmithKline plc

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes